International Journal of
Genetics and Molecular Biology

  • Abbreviation: Int. J. Genet. Mol. Biol.
  • Language: English
  • ISSN: 2006-9863
  • DOI: 10.5897/IJGMB
  • Start Year: 2009
  • Published Articles: 115

Full Length Research Paper

Genetic polymorphism of vesicular monoamine transporter 1 gene (SLC18A1) in Emirati population

Abdullah Al Mutery
  • Abdullah Al Mutery
  • Department of Applied Biology, University of Sharjah, Sharjah, United Arab Emirates.
  • Google Scholar
Walaa Kamal
  • Walaa Kamal
  • Department of Applied Biology, University of Sharjah, Sharjah, United Arab Emirates.
  • Google Scholar
Hawraa Abduljalil Hussein Al Bloushi
  • Hawraa Abduljalil Hussein Al Bloushi
  • School of Life Sciences, Manipal University, Dubai, United Arab Emirates.
  • Google Scholar
Mary Sebastian Manjuran
  • Mary Sebastian Manjuran
  • School of Life Sciences, Manipal University, Dubai, United Arab Emirates.
  • Google Scholar
Naushad Rais
  • Naushad Rais
  • School of Life Sciences, Manipal University, Dubai, United Arab Emirates.
  • Google Scholar


  •  Received: 09 December 2016
  •  Accepted: 24 March 2017
  •  Published: 31 May 2017

References

Berrettini W (2003). Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am. J. Med. Genet.123C:59-64.
Crossref

 

Bly M (2005). Mutation in the vesicular monoamine gene, SLC18A1, associated with schizophrenia. Schizophr. Res. 78:337-338.
Crossref

 
 

Brunk I, Blex C, Rachakonda S, HoltjeM, Winter S, Pahner I, Walther DJ, Ahnert-Hilger G (2006). The first luminaldomain of vesicular monoamine transportersmediates G-protein-dependent regulationof transmitter uptake. J. Biol. Chem. 281:33373-33385.
Crossref

 
 

Charney DS, Deutch A (1996). Afunctional neuroanatomy of anxiety and fear: implications for the pathophysiology andtreatment of anxiety disorders. Crit. Rev. Neurobiol.10:419-446.
Crossref

 
 

Chen SF, Chen CH, Chen JY, WangYC, Lai IC, Liou YJ, Liao DL (2007). Support for association of the A277Csingle nucleotide polymorphism in humanvesicular monoamine transporter 1 gene withschizophrenia. Schizophr. Res.90:363-365.
Crossref

 
 

Cordeiro ML, Gundersen CB, Umbach JA (2002). Lithium ions modulate the expression of VMAT2 in ratbrain. Brain Res. 953:189-194.
Crossref

 
 

Cordeiro ML, Gundersen CB, Umbach JA (2004). Convergent effects of lithium and valproate on theexpression of proteins associated with large dense core vesicles in NGF-differentiated PC12 cells. Neuropsychopharmacology 29:39-44.
Crossref

 
 

Cordeiro ML, Umbach JA, Gundersen CB (2000). Lithium ions Up-regulate mRNAs encoding dense-corevesicle proteins in nerve growth factor-differentiated PC12 cells. J. Neurochem. 75:2622-2625.
Crossref

 
 

Eiden LE, Schafer MK, Weihe E, Schutz, B (2004). The vesicular aminetransporter family (SLC18): amine/protonantiporters required for vesicular accumulationand regulated exocytotic secretionof monoamines and acetylcholine. PflugersArch.447:636-640
Crossref

 
 

Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E (1996). Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA. 93:5166-5171.
Crossref

 
 

Haider S, Ballester B, Smedley D, Zhang J, Rice P,Kasprzyk A (2009). BioMart Central Portal-unified access to biological data. Nucl. Acids Res. 37:W23-W27.
Crossref

 
 

Handley SL (1995). 5-Hydroxytryptaminepathways in anxiety and its treatment. Pharmacol. Ther.66:103-148.
Crossref

 
 

Hansson SR, Hoffman BJ, MezeyE (1998). Ontogeny of vesicular monoaminetransporter mRNAs VMAT1 and VMAT2. I.The developing rat central nervous system.Brain Res. Dev. Brain Res. 110:135-158.
Crossref

 
 

Khalifa AM, Watson-Siriboe A, Shukry SG, Chiu WL, Nelson ME, Geng Y, Fischer-Stenger K, Porter JH, Stewart JK (2012). Thr136Ile polymorphism of human monoamine transporter-1 (SLC18A1gene) influences its transport activity in vitro. NeuroEndocrinol. Lett. 33(5):546-551.

 
 

Lohoff FW (2010). Genetic Variants in the Vesicular Monoamine Transporter 1(VMAT1/SLC18A1) and Neuropsychiatric Disorders. In: Qing Yan (Ed). Membrane Transporters in Drug Discovery and Development- Methods and Protocols. New York: Humana press, pp. 165-180.
Crossref

 
 

Lohoff FW, Dahl JP, Ferraro TN,Arnold SE, Gallinat J, Sander T,Berrettini WH (2006). Variations in thevesicular monoamine transporter 1 gene(VMAT1/SLC18A1) are associated withbipolar I disorder. Neuropsychopharmacology. 31:2739-2747.
Crossref

 
 

Lohoff FW, Weller AE, Bloch PJ, Buono RJ, Doyle GA, Ferraro TN et al (2008a). Associationbetween polymorphisms in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) on chromosome 8p and schizophrenia. Neuropsychobiology 57:55-60.
Crossref

 
 

Lohoff FW, Lautenschlager M, MohrJ, Ferraro TN, Sander T, GallinatJ (2008b). Association between variationin the vesicular monoamine transporter1 gene on chromosome 8p and anxiety related personality traits. Neurosci. Lett. 434:41-45.
Crossref

 
 

Lohoff FW, Hodge R, NarasimhanS, NallA, Ferraro TN, Mickey BJ, Heitzeg MM, Langenecker SA, Zubieta JK, Bogdan R, NikolovaY S, Drabant E, Hariri AR, Bevilacqua L, Goldman D, Doyle GA (2014). Functional genetic variants in the vesicular monoaminetransporter 1 (VMAT1) modulate emotion processing. Mol. Psychiatry. 19(1):129-139.
Crossref

 
 

Liu Y, Edwards RH (1997). The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu. Rev. Neurosci. 20:125-156.
Crossref

 
 

Peter D, Finn JP, Klisak, I, Liu Y, Kojis T, Heinzmann C, Roghani A., SparkesRS,Edwards RH (1993). Chromosomal localizationof the human vesicular amine transporter genes. Genomics.18: 720–723.
Crossref

 
 

Richards M, Iijima Y, Kondo H, ShizunoT, Hori H, Arima K, Saitoh O, Kunugi H (2006). Association studyof the vesicular monoamine transporter 1(VMAT1) gene with schizophrenia in aJapanese population. Behav. Brain Funct. 2:39-45.
Crossref

 
 

Senkowski D, Linden M, ZubragelD,Bar T,Gallinat J (2003). Evidencefor disturbed cortical signal processing andaltered serotonergic neurotransmission ingeneralized anxiety disorder. Biol. Psychiatry.53:304-314.
Crossref

 
 

Sievert MK, Ruoho AE (1997). Peptide mapping of the [125I]Iodoazidoketanserinand [125I]2-N-[(3_-iodo-4_-azidophenyl)propionyl]tetrabenazine binding sites for the synaptic vesiclemonoamine transporter. J. Biol. Chem.272: 26049–26055.
Crossref